Top Stories
-
Columbia research seven years in the making highlights potential therapeutic target for neurodegenerative disease
Topic
-
Biogen’s Aduhelm is the first approved treatment for early stage Alzheimer’s patients that may be able to slow the disease.
Topic
-
A recent look inside a baby zebrafish's transparent brain offers clues to how we remember and how we forget.
Topic
-
There is a robust market for books that praise our seemingly feeble habits of mind.
Topic
Latest News
- June 28, 2021
The federal health insurance program may limit who can get the drug, which Biogen priced at $56,000 a year, to limit the financial impact
Topic
- June 8, 2021
On Monday, the FDA approved a new drug for Alzheimer’s disease—the first in nearly two decades. Biogen’s aducanumab aims to slow the cognitive decline often associated with the disease.
Topic
- June 7, 2021
After exercising, choose a brain-healthy recovery meal.
Topic
- June 4, 2021
Other researchers are not convinced that these biomarkers vary by race, primarily because so little Alzheimer’s research has been conducted on Black and Latinx people.
Topic
-
Source:
ForbesMay 21, 2021It is well established that people who had fewer opportunities to receive education when they were children are at higher risk for Alzheimer’s disease later in life, noted Dr. Jennifer Manly
Topic
-
Source:
CUIMC NewsroomMarch 30, 2021A new study on COVID-19 patients with dementia led by James Noble, MD, MS associate professor of neurology at CUIMC
Topic
- March 15, 2021
During March, Women’s History Month, CUMC is sharing the stories of some of the many women who are spearheading innovation through research, patient care, and education.
Topic
-
Source:
The Wall Street JournalDecember 28, 2020New research could explain why COVID-19 survivors face neurological symptoms months after getting sick. ADRC Development Grant awardee Dr. Anna Nordvig discusses how the coronavirus affects the brain.
Topic
-
Source:
AlzforumDecember 11, 2020It is difficult to isolate large quantities of microglia from human brain. That’s why scientists still know little about the different ways these cells rear up in health and disease.
Topic
-
Source:
Cold Spring Harbor LaboratoryDecember 9, 2020Neurodegenerative Disease Conference 2020: ADRC Cold Spring Harbor Panel featuring Dr. Anna Nordvig.
Topic
